Sreya Sherin Biju, Ravi Prakash Arya, Anismrita Lahon
{"title":"TRIM28 and TRIM32: multifaceted regulators of innate immunity and antiviral defence.","authors":"Sreya Sherin Biju, Ravi Prakash Arya, Anismrita Lahon","doi":"10.1007/s12026-026-09799-7","DOIUrl":null,"url":null,"abstract":"<p><p>As versatile E3 ubiquitin ligases, Tripartite Motif (TRIM) proteins are essential elements of the innate immune response. The antiviral roles of TRIM28 and TRIM32 have been well documented, and they function in different ways. TRIM28 regulates the transcriptional expression of antiviral genes, while TRIM32 ubiquitinates host or viral proteins and directs their proteasomal breakdown. When taken together, they represent complementary transcriptional and post-translational host defence mechanisms. While TRIM28 primarily acts as a transcriptional repressor and TRIM32 as an E3 ubiquitin ligase, both proteins also play opposing roles in cell differentiation and immunity. Given the large number of TRIM family members, focusing on these two allows us to present representative transcriptional and ubiquitination-mediated regulatory mechanisms in depth. This review focuses on the regulatory differences in TRIM28 and TRIM32 in RIG-like receptor (RLR) signalling, Stimulator of Interferon Genes (STING) pathways, Toll-like receptor (TLR) signalling, and NOD-like receptors (NLR)-mediated inflammation, which are key to the host's immune response. These protein interactomes exhibit a significant interaction with other cellular pathways, broadening their significance beyond antiviral responses to encompass broader genetic and therapeutic implications.</p>","PeriodicalId":13389,"journal":{"name":"Immunologic Research","volume":"74 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunologic Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12026-026-09799-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
As versatile E3 ubiquitin ligases, Tripartite Motif (TRIM) proteins are essential elements of the innate immune response. The antiviral roles of TRIM28 and TRIM32 have been well documented, and they function in different ways. TRIM28 regulates the transcriptional expression of antiviral genes, while TRIM32 ubiquitinates host or viral proteins and directs their proteasomal breakdown. When taken together, they represent complementary transcriptional and post-translational host defence mechanisms. While TRIM28 primarily acts as a transcriptional repressor and TRIM32 as an E3 ubiquitin ligase, both proteins also play opposing roles in cell differentiation and immunity. Given the large number of TRIM family members, focusing on these two allows us to present representative transcriptional and ubiquitination-mediated regulatory mechanisms in depth. This review focuses on the regulatory differences in TRIM28 and TRIM32 in RIG-like receptor (RLR) signalling, Stimulator of Interferon Genes (STING) pathways, Toll-like receptor (TLR) signalling, and NOD-like receptors (NLR)-mediated inflammation, which are key to the host's immune response. These protein interactomes exhibit a significant interaction with other cellular pathways, broadening their significance beyond antiviral responses to encompass broader genetic and therapeutic implications.
期刊介绍:
IMMUNOLOGIC RESEARCH represents a unique medium for the presentation, interpretation, and clarification of complex scientific data. Information is presented in the form of interpretive synthesis reviews, original research articles, symposia, editorials, and theoretical essays. The scope of coverage extends to cellular immunology, immunogenetics, molecular and structural immunology, immunoregulation and autoimmunity, immunopathology, tumor immunology, host defense and microbial immunity, including viral immunology, immunohematology, mucosal immunity, complement, transplantation immunology, clinical immunology, neuroimmunology, immunoendocrinology, immunotoxicology, translational immunology, and history of immunology.